Blood test vs pap smear: which detects cervical cancer better?

NCT ID NCT07480902

Recruiting now Diagnosis Sponsor: Timser SAPI de CV Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares the standard Pap smear with a new blood test that looks for three proteins to detect early cervical changes and cancer. About 558 women aged 18-85 will participate. The goal is to see if the blood test is as good or better at finding problems early.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for I) ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Atypical Squamous Cells of the Cervix cervical carcinoma cervical intraepithelial neoplasia dysplasia of cervix squamous carcinoma in situ squamous cell intraepithelial neoplasia Squamous Intraepithelial Lesions Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

I) ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE (ASC-US) II) ATYPICAL GLANDULAR CELLS OF UNCERTAIN SIGNIFICANCE (AGUS) III) CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN), CIN-1, CIN-2, CIN-3 IV) LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESION (LSIL) V) HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL) VI) CERVICAL CANCER

Contacts and locations

Locations

Consultorio Médico TIMSER
RECRUITING

Mexico City, Mexico City, 14210, Mexico